Scribe Therapeutics Shares Rise in Nasdaq Debut

MT Newswires Live

3小时前

Scribe Therapeutics (SCTX) shares were up sharply in their Friday debut on Nasdaq after the company priced its initial public offering of 8.58 million shares at $15.00 per share.

The stock opened at $25 and was up over 50% at around $22.61 after midday.

The clinical-stage biotechnology company has upsized its IPO after pricing the shares at the high end of its indicative range.

It has granted its underwriters a 30-day option to purchase up to almost 1.3 million additional shares. Leerink Partners, Goldman Sachs, Guggenheim Securities and Wells Fargo Securities are joint book-running managers for the offering.

Price: 22.61, Change: +7.61, Percent Change: +50.75

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2654039861"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2654039861\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2654039861?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-25 00:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2654039861","market":"us","top_or_hot":-1,"title":"Scribe Therapeutics Shares Rise in Nasdaq Debut","media":"MT Newswires Live","content":"<html><body><p> Scribe <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (SCTX) shares were up sharply in their Friday debut on Nasdaq after the company priced its initial public offering of 8.58 million shares at $15.00 per share.</p><p>The stock opened at $25 and was up over 50% at around $22.61 after midday.</p><p>The clinical-stage biotechnology company has upsized its IPO after pricing the shares at the high end of its indicative range.</p><p>It has granted its underwriters a 30-day option to purchase up to almost 1.3 million additional shares. Leerink Partners, Goldman Sachs, Guggenheim Securities and <a href=\"https://laohu8.com/S/EOD\">Wells Fargo</a> Securities are joint book-running managers for the offering.</p><p>Price: 22.61, Change: +7.61, Percent Change: +50.75</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Scribe Therapeutics Shares Rise in Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nScribe Therapeutics Shares Rise in Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-07-25 00:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Scribe <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (SCTX) shares were up sharply in their Friday debut on Nasdaq after the company priced its initial public offering of 8.58 million shares at $15.00 per share.</p><p>The stock opened at $25 and was up over 50% at around $22.61 after midday.</p><p>The clinical-stage biotechnology company has upsized its IPO after pricing the shares at the high end of its indicative range.</p><p>It has granted its underwriters a 30-day option to purchase up to almost 1.3 million additional shares. Leerink Partners, Goldman Sachs, Guggenheim Securities and <a href=\"https://laohu8.com/S/EOD\">Wells Fargo</a> Securities are joint book-running managers for the offering.</p><p>Price: 22.61, Change: +7.61, Percent Change: +50.75</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SCTX","symbol_name":"Scribe Therapeutics, Inc.","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2654039861","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2654039861","pubTimestamp":1784912164,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Scribe Therapeutics  shares were up sharply in their Friday debut on Nasdaq after the company priced its initial public offering of 8.58 million shares at $15.00 per share.The stock opened at $25 and was up over 50% at around $22.61 after midday.The clinical-stage biotechnology company has upsized its IPO after pricing the shares at the high end of its indicative range.It has granted its underwriters a 30-day option to purchase up to almost 1.3 million additional shares. Leerink Partners, Goldman Sachs, Guggenheim Securities and Wells Fargo Securities are joint book-running managers for the offering.Price: 22.61, Change: +7.61, Percent Change: +50.75","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SCTX":"Scribe Therapeutics, Inc.","LCLG":"Logan Capital Broad Innovative Growth ETF"},"translate_title":"Scribe Therapeutics 股价在纳斯达克首次亮相时上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SCTX":1.5,"LCLG":1.5,"NQmain":1.5},"content_text":"Scribe Therapeutics (SCTX) shares were up sharply in their Friday debut on Nasdaq after the company priced its initial public offering of 8.58 million shares at $15.00 per share.The stock opened at $25 and was up over 50% at around $22.61 after midday.The clinical-stage biotechnology company has upsized its IPO after pricing the shares at the high end of its indicative range.It has granted its underwriters a 30-day option to purchase up to almost 1.3 million additional shares. Leerink Partners, Goldman Sachs, Guggenheim Securities and Wells Fargo Securities are joint book-running managers for the offering.Price: 22.61, Change: +7.61, Percent Change: +50.75","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}